Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
Florian Voit, Caroline Isner, N. Stobäus, Antonio Losa Carmona et al.
Citations
17 citations
Journal
The Lancet Infectious Diseases
Topics
Poxvirus research and outbreaks
Field-Weighted Citation Impact (FWCI)
17.62
article
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
Florian Voit, Caroline Isner, N. Stobäus, Antonio Losa Carmona, Anja Potthoff, Hartmut Stocker, Thomas Wünsche, Marcel Lee, David Hillus, Markus Bickel, Pinkus Tober‐Lau, Regina Stegherr, Hubert Schulbin, Ran D. Balicer, Anne‐Katrin Fietz, Christoph Wyen, Ngoc Han Le, Gal Goldstein, Christian Hoffmann, Christiane Cordes, Bethany Knox, Axel Baumgarten, Luyan Huang, M. Vallée, Ulrich Bohr
article en
17 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Infectious DiseasesVol. 25(7)
Institutions
TUM Klinikum (DE), LMU Klinikum (DE), Humboldt-Universität zu Berlin (DE), Auguste-Viktoria-Klinik (DE), Zimmer Biomet (Germany) (DE), Aetion (United States) (US), Infektionsmedizinisches Centrum Hamburg (DE), Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), St. Joseph-Krankenhaus (DE), Klinikum im Friedrichshain (DE), University Hospital Cologne (DE), Orthopädische Praxis (DE), Zentrum für Pathologie und Zytodiagnostik (DE), Clalit Health Services (IL), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), Ruhr University Bochum (DE), Praxis (EE)